A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 2, 2010, Pages 144-149

  Phelip, J M ^a   Molinie F ^b   Delafosse, P ^b   Launoy, G ^b   Tretarre B ^b   Bara, S ^b   Buemi A ^b   Velten, M ^b   Danzon, A ^b   Ganry, O ^b   Bouvier, A M ^a,b   Grosclaude, P ^b   Faivre, J ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CANCER STAGING; CLINICAL FEATURE; COLON CANCER; COLON RESECTION; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; INFORMATION PROCESSING; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FRANCE; HUMANS; INTESTINAL OBSTRUCTION; INTESTINAL PERFORATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT CARE TEAM; REGISTRIES; SAMPLING STUDIES;

EID: 77249088788     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.08.012     Document Type: Article

References (32)

1. Laurie J.A., Moertel C.G., Fleming T.R., Wieand H.S., Leigh J.E., Rubin J., et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7 (1989) 1447-1456
2. Moertel C.G., Fleming T.R., Macdonald J.S., Haller D.G., Laurie J.A., Goodman P.J., et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322 (1990) 352-358
3. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345 (1995) 939-944
4. Consensus N.I.H. conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 264 (1990) 1444-1450
5. Schrag D., Cramer L.D., Bach P.B., and Begg C.B. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93 (2001) 850-857
6. Phelip J.M., Grosclaude P., Launoy G., Colonna M., Danzon A., Velten M., et al. Are there regional differences in the management of colon cancer in France?. Eur J Cancer Prev 14 (2005) 31-37
7. Consensus conference. Prevention, diagnosis and treatment of colon cancer. Gastroenterol Clin Biol 22 (1998) 205-226
8. Mamounas E., Wieand S., Wolmark N., Bear H.D., Atkins J.N., Song K., et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03 and C-04). J Clin Oncol 17 (1999) 1349-1355
9. Benson III A.B., Schrag D., Somerfield M.R., Cohen A.M., Figueredo A.T., Flynn P.J., et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22 (2004) 3408-3419
10. Cronin D.P., Harlan L.C., Potosky A.L., Clegg L.X., Stevens J.L., and Mooney M.M. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101 (2006) 2308-2318
11. Dobie S.A., Baldwin L.M., Dominitz J.A., Matthews B., Billingsley K., and Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 98 (2006) 610-619
12. Jessup J.M., Stewart A., Greene F.L., and Minsky B.D. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294 (2005) 2703-2711
13. Neugut A.I., Fleischauer A.T., Sundararajan V., Mitra N., Heitjan D.F., Jacobson J.S., et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 20 (2002) 2643-2650
14. Potosky A.L., Harlan L.C., Kaplan R.S., Johnson K.A., and Lynch C.F. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 (2002) 1192-1202
15. Lemmens V.E., van Halteren A.H., Janssen-Heijnen M.L., Vreugdenhil G., Repelaer van Driel O.J., and Coebergh J.W. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 16 (2005) 767-772
16. Bouchardy C., Queneau P.E., Fioretta G., Usel M., Zellweger M., Neyroud I., et al. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice. Br J Cancer 85 (2001) 1251-1257
17. Alter E., Phelip J.M., Guilhot J.N., Matysiak M., Vermorel M., and Roblin X. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice. Eur J Gastroenterol Hepatol 19 (2007) 995-1001
18. Illustrated Guide to the TNM/PTNM Classification of Malignant Tumours, 4th ed. UICC. TNM Atlas. Berlin: Springer-Verlag; 1997:98-106
19. Schrag D., Rifas-Shiman S., Saltz L., Bach P.B., and Begg C.B. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol 20 (2002) 3999-4005
20. Haward R.A. Using service guidance to shape the delivery of cancer services: experience in the UK. Br J Cancer 89 Suppl. 1 (2003) S12-S14
21. Jessup J.M., McGinnis L.S., Steele Jr. G.D., Menck H.R., and Winchester D.P. The National Cancer Data Base. Report on colon cancer. Cancer 78 (1996) 918-926
22. Andre T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350 (2004) 2343-2351
23. Mahoney T., Kuo Y.H., Topilow A., and Davis J.M. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg 135 (2000) 182-185
24. Jouve J.L., Mitry E., Phelip J.M., Villing A.L., Tazi M.A., and Faivre J. Adjuvant chemotherapy for colon adenocarcinoma in the county of Cote-d'Or. Gastroenterol Clin Biol 22 (1998) 269-272
25. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., Manfredi S., Dancourt V., and Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 51 (2002) 60-64
26. Ayanian J.Z., Zaslavsky A.M., Fuchs C.S., Guadagnoli E., Creech C.M., Cress R.D., et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21 (2003) 1293-1300
27. Sundararajan V., Mitra N., Jacobson J.S., Grann V.R., Heitjan D.F., and Neugut A.I. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 136 (2002) 349-357
28. Sargent D.J., Goldberg R.M., Jacobson S.D., Macdonald J.S., Labianca R., Haller D.G., et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345 (2001) 1091-1097
29. Kohne C.H., Grothey A., Bokemeyer C., Bontke N., and Aapro M. Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 12 (2001) 435-442
30. Popescu R.A., Norman A., Ross P.J., Parikh B., and Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 17 (1999) 2412-2418
31. Yellen S.B., Cella D.F., and Leslie W.T. Age and clinical decision making in oncology patients. J Natl Cancer Inst 86 (1994) 1766-1770
32. Newcomb P.A., and Carbone P.P. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 85 (1993) 1580-1584